Amyloidosis, Evans syndrome and management options of lymphoplasmacytic lymphoma

References

• Fonseca R, Hayman S. Waldenström macroglobulinaemia. Br J Haematol 2007; 138: 700–720
   PubMed Web of Science ®Google Scholar
• Jønsson V, Kierkegaard A, Salling S, Molander S, Andersen L P, Christiansen M, Wiik A. Autoimmunity in Waldenström's macroglobulinaemia. Leuk Lymphoma 1999; 34: 373–379
   PubMed Web of Science ®Google Scholar
• Kyrtsonis M C, Vassilakopoulos T P, Angelopoulou M K, Siakantaris P, Kontopidou F N, Dimopoulou M N, Boussiotis V, Gribabis A, Konstantopoulos K, Vaiopoulos G A, Fessas P, Kittas C, Pangalis G A. Waldenström's macroglobulinemia: clinical course and prognostic factors in 60 patients. Experience from a single hematology unit. Ann Hematol 2001; 80: 722–727
   PubMed Web of Science ®Google Scholar
• Poulain S, Dervite I, Leleu X, Fernandes J, Stalnikiewicz L, Moreau A S, Coiteux V, de Botton S, Duthilleul P, Morel P. Autoimmune hemolytic anemias and IgG antierythrocyte autoantibodies in Waldenström's macroglobulinemia: association with FcgammaRIIa polymorphism. Leukemia 2006; 20: 1179–1181
   Google Scholar
• Tanaka T, Ueda N, Fujita M, Oka A, Tanaka S, Sezaki T, Yamamoto K, Shiomi H. Macroglobulinemia Waldenström complicated by autoimmune hemolytic anemia, meningeal sign and femoral lysis. Acta Pathol Jpn 1979; 29: 777–789
   Google Scholar
• Gologan R, Dima I, Butoianu E, Nicoară S, Coliţă D. Autoimmune hemolytic anemia with warm antibodies complicated with an intercurrent attack of hemolysis with cold agglutinins in a case of Waldenström disease. Rom J Intern Med 1996; 34: 149–154
   Google Scholar
• Crisp D, Pruzanski W. B-cell neoplasms with homogeneous cold-reacting antibodies (cold agglutinins). Am J Med 1982; 72: 915–922
   PubMed Web of Science ®Google Scholar
• Ozaki S, Kawachi Y, Sakamoto Y, Igaki T, Ogasawara N, Uchida T, Mori M, Setu K. Chronic cold agglutinin disease terminating in primary macroglobulinemia after a 10 year history. Rinsho Ketsueki 1992; 33: 1720–1724
   Google Scholar
• Suzuki M, Noda T, Kodama H, Sahashi K, Wakita A. A case of Waldenström's macroglobulinemia with cold agglutinin disease. Rinsho Ketsueki 1986; 27: 376–380
   Google Scholar
• Owen R G, Lubenko A, Savage J, Parapia L A, Jack A S, Morgan G J. Autoimmune thrombocytopenia in Waldenström's macroglobulinemia. Am J Hematol 2001; 66: 116–119
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Nagata K, Hamaguchi H. Elevated platelet-associated IgG in immune thrombocytopenic purpura associated with Waldenström's macroglobulinemia. Am J Hematol 2002; 69: 85–86
   PubMed Web of Science ®Google Scholar
• Patel T C, Moore S B, Pineda A A, Witzig T E. Role of plasmapheresis in thrombocytopenic purpura associated with Waldenström's macroglobulinemia. Mayo Clin Proc 1996; 71: 597–600
   Google Scholar
• Rajkumar S V, Gertz M A, Kyle R A. Primary systemic amyloidosis with delayed progression to multiple myeloma. Cancer 1998; 82: 1501–1505
   PubMed Web of Science ®Google Scholar
• Gardyn J, Schwartz A, Gal R, Lewinski U, Kristt D, Cohen A M. Waldenström's macroglobulinemia associated with AA amyloidosis. Int J Hematol 2001; 74: 76–78
   Google Scholar
• Gertz M A, Kyle R A, Noel P. Primary systemic amyloidosis: a rare complication of immunoglobulin M monoclonal gammapathies and Waldenström's macroglobulinemia. J Clin Oncol 1993; 11: 914–920
   PubMed Web of Science ®Google Scholar
• Gertz M A, Kyle R A. Amyloidosis with IgM monoclonal gammopathies. Semin Oncol 2003; 30: 325–328
   PubMed Web of Science ®Google Scholar
• Terrier B, Jaccard A, Harousseau J L, Delarue R, Tournilhac O, Hunault-Berger M, Hamidou M, Dantal J, Bernard M, Grosbois B, Morel P, Coiteux V, Gisserot O, Rodon P, Hot A, Elie C, Leblond V, Fermand J P, Fakhouri F. The clinical spectrum of IgM-related amyloidosis: a French nationwide retrospective study of 72 patients. Medicine (Baltimore) 2008; 87: 99–109
   PubMed Web of Science ®Google Scholar
• Aslan D L, Peterson B A, Long-Tsai M, Eastlund T. Early-onset autoimmune hemolytic anemia after cladribine therapy for Waldenström's macroglobulinemia. Transfusion 2006; 46: 90–94
   PubMed Web of Science ®Google Scholar
• Tetreault S A, Saven A. Delayed onset of autoimmune hemolytic anemia complicating cladribine therapy for Waldenström macroglobulinemia. Leuk Lymphoma 2000; 37: 125–130
   PubMed Web of Science ®Google Scholar
• Norton A, Roberts I. Management of Evans syndrome. Br J Haematol 2006; 132: 125–137
   PubMed Web of Science ®Google Scholar
• Plevová P, Cermáková R, Lochmanová A, Pták J, Blazek B, Starý J. Evans' syndrome in a child with diabetes mellitus. Pediatr Hematol Oncol 1998; 15: 353–357
   PubMed Web of Science ®Google Scholar
• Yashiro M, Nagoshi H, Kasuga Y, Isobe H, Kitajima S, Nakagawa T, Ohshima J, Ide K, Someya K, Saito N. Evans' syndrome associated with Graves' disease. Intern Med 1996; 35: 987–990
   Google Scholar
• Cervera H, Jara L J, Pizarro S, Enkerlin H L, Fernandez M, Medina F, Fraga A, Miranda J M. Danazol for systemic lupus erythematosus with refractory autoimmune thrombocytopenia or Evans' syndrome. J Rheumatol 1995; 22: 1867–1871
   Google Scholar
• Nordlinger M, Magnani B, Skinner M, Falk R H. Is elevated plasma B-natriuretic peptide in amyloidosis simply a function of the presence of heart failure. Am J Cardiol 2005; 96: 982–984
   PubMed Web of Science ®Google Scholar
• Murtagh B, Hammill S C, Gertz M A, Kyle R A, Tajik A J, Grogan M. Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement. Am J Cardiol 2005; 95: 535–537
   PubMed Web of Science ®Google Scholar
• Cueto-Garcia L, Reeder G S, Kyle R A, Wood D L, Seward J B, Naessens J, Offord K P, Greipp P R, Edwards W D, Tajik A J. Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol 1985; 6: 737–743
   PubMed Web of Science ®Google Scholar
• Klein A L, Hatle L K, Taliercio C P, Oh J K, Kyle R A, Gertz M A, Bailey K R, Seward J B, Tajik A J. Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study. Circulation 1991; 83: 808–816
   PubMed Web of Science ®Google Scholar
• Mori A, Tamaru J, Sumi H, Kondo H. Beneficial effects of rituximab on primary cold agglutinin disease refractory to conventional therapy. Eur J Haematol 2002; 68: 243–246
   PubMed Web of Science ®Google Scholar
• Clavio M, Quintino S, Venturino C, Ballerini F, Varaldo R, Gatto S, Galbusera V, Garrone A, Grasso R, Canepa L, Miglino M, Pierri I, Gobbi M. Lymphoplasmacytic lymphoma/immunocytoma: towards a disease-targeted treatment. J Exp Clin Cancer Res 2001; 20: 351–358
   Google Scholar
• Simmonds P D, Cottrell B J, Mead G M, Wright D H, Whitehouse J M. Lymphadenopathy due to amyloid deposition in non-Hodgkin's lymphoma. Ann Oncol 1997; 8: 267–270
   PubMedGoogle Scholar
• Cohen A D, Zhou P, Xiao Q, Fleisher M, Kalakonda N, Akhurst T, Chitale D A, Moscowitz C, Dhodapkar M V, Teruya-Feldstein J, Filippa D, Comenzo R L. Systemic AL amyloidosis due to non-Hodgkin's lymphoma: an unusual clinicopathologic association. Br J Haematol 2004; 124: 309–314
   PubMed Web of Science ®Google Scholar
• Treon S P, Hunter Z R, Matous J, Joyce R M, Mannion B, Advani R, Cook D, Songer J, Hill J, Kaden B R, Sharon D, Steiss R, Leleu X, Branagan A R, Badros A. Multicenter clinical trial of bortezomib in relapsed/refractory Waldenstrom's macroglobulinemia: results of WMCTG trial 03-248. Clin Cancer Res 2007; 13: 3320–3325
   PubMed Web of Science ®Google Scholar